Tag: GlobalData

Chips, China, and a Lot of Money: The Factors Driving the DeepSeek AI Turmoil

Chips, China, and a Lot of Money: The Factors Driving the DeepSeek AI Turmoil Why is DeepSeek causing global technology shockwaves? Matt Sheehan: DeepSeek is a Chinese AI startup that recently released a series of very impressive generative AI models. One of those models, DeepSeek R1, is a “reasoning model” that takes its time to think through an extended chain of logic before it gives an answer....

China February 19, 2025

Market Thoughts – Subdued Start To Holiday-Shortened Week

Market Thoughts – Subdued Start To Holiday-Shortened Week Today’s market analysis on behalf of Michael Brown Senior Research Strategist at Pepperstone DIGEST – Markets started the week in subdued fashion yesterday, with US participants away for Presidents’ Day. Today, UK jobs, German sentiment, and Canadian inflation figures are in focus. ued fashion yesterday, with US participants away for Presidents’ Day. Today, UK jobs, German sentiment, and Canadian inflation figures are...

Economy February 18, 2025

Tag: GlobalData

Chips, China, and a Lot of Money: The Factors Driving the DeepSeek AI Turmoil

Market Thoughts – Subdued Start To Holiday-Shortened Week

Top M&A financial and legal advisers in Europe for H1 2024

South Korea card payments market to reach almost $1 trillion in 2024

US jobs slowdown expected to be below 8 million for first time in over 3 years

India startups raise $3.9 billion in VC funding during first five months of 2024

High value deal volume decline reflects shift in investor strategies in 2023

US and China dominate global high value VC funding deals volume with 70% share in 2023

VC funding in India down by more than half to $7.8 billion in 2023

UK venture funding value down by 39.4% to $14.2 billion in 2023

North America companies dominate Forbes 2000 list with $19.3 trillion revenue in 2023

France set to be most visited country in the world by 2025

How much the Energy transition drove the 20 M&A deals in mining

Top 20 global biopharmaceutical companies report 9.1% QoQ decline